Side-by-side financials for ABEO and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABEO | NVS |
|---|---|---|
| Market cap | - | $292.08 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $5.82M | - |
| Net income (latest FY) | -$71.18M | - |
| Net margin | -1223.1% | - |
| SEC filings | 1,000 | 947 |
Full pages: ABEONA THERAPEUTICS INC. and Novartis AG, or browse the full rankings.